Q3 2025 Management View CEO Sean Nolan stated, “The recent regulatory clarity and progress we've achieved, which was enabled ...
Tenaya Therapeutics said on Friday the U.S. Food and Drug Administration has placed a clinical hold on its trial of an experimental gene therapy for a type of rare inherited heart disease. Shares of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback